The table below shows the adverse reactions of interest that happened
during the study.
Adverse reactions of interest during this study
Dapagliflozin Placebo
Adverse reaction of (out of 2,149 (out of 2,149
interest participants) participants)
Symptoms of low levels
2.5% (54) 1.4% (30)
of liquids in the body
Kidney problems 1.6% (35) 1.3% (27)
Any bone fractures 0.2% (4) 0.1% (3)
Amputation 0.1% (3) 0.1% (2)
Decreased blood sugar
0.1% (2) 0.3% (6)
problems
High levels of ketones in
the blood caused by low 0.0% (0) 0.1% (1)
levels of insulin
How has this study helped patients and
researchers?
This study helped researchers learn how dapagliflozin affects the kidneys in
participants who have CKD.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this 1 study.
Other studies may provide new information or different results.
Further clinical studies with dapagliflozin are planned.
11 | Clinical Study Results